Published in Cancer Weekly, May 8th, 2001
While differentiation-inducing agents such as these have demonstrated minimal cancer inhibition when used as monotherapies in clinical experiments, a combination of these agents has resulted in marked effects in cultured cancer cells and in engrafted animals, Johns Hopkins researchers state.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.